Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Cooper

Showing results (211-220 of 253) with videos related to

Pageof 26
Sort By:
JCI Insight|January 3, 2020
Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohortWilliam Z Zhang, Michelle C Rice, Katherine L Hoffman, et al.
American Journal of Respiratory and Critical Care Medicine|May 10, 2022
Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary DiseaseSiddharth S Madapoosi, Charmion Cruickshank-Quinn, Kristopher Opron, et al.
The Lancet. Digital Health|January 27, 2023
Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation studyMuhammad F A Chaudhary, Eric A Hoffman, Junfeng Guo, et al.
American Journal of Respiratory and Critical Care Medicine|March 20, 2024
The Effect of Chronic Altitude Exposure on Chronic Obstructive Pulmonary Disease Outcomes in the SPIROMICS Cohort: An Observational Cohort StudyRajat Suri, Daniela Markovic, Han Woo, et al.
Annals of the American Thoracic Society|March 11, 2025
Longitudinal Outcomes in Pi*MZ Alpha-1 Antitrypsin Deficient Individuals with Tobacco Smoking History from the SPIROMICS CohortIgor Barjaktarevic, Roxana Hixson, Zian Zhuang, et al.
Annals of the American Thoracic Society|November 25, 2024
Phenotypes and Trajectories of Tobacco-exposed Persons with Preserved Spirometry: Insights from Lung VolumesMehrdad Arjomandi, Siyang Zeng, Igor Barjaktarevic, et al.
American Journal of Respiratory and Critical Care Medicine|October 2, 2020
Contribution of Individual and Neighborhood Factors to Racial Disparities in Respiratory OutcomesChinedu O Ejike, Han Woo, Panagis Galiatsatos, et al.
Annals of the American Thoracic Society|May 2, 2017
Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study CohortCarlos H Martinez, Susan Murray, R Graham Barr, et al.
Journal of Medicinal Chemistry|June 2, 2012
Diphenylpyridylethanamine (DPPE) derivatives as cholesteryl ester transfer protein (CETP) inhibitorsLalgudi S Harikrishnan, Heather J Finlay, Jennifer X Qiao, et al.
JCI Insight|June 24, 2024
Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohortWilliam Z Zhang, Michelle C Rice, Katherine L Hoffman, et al.
Pageof 26

Showing results (211-220 of 253) with videos related to

Sort By:
Pageof 26
JCI Insight|January 3, 2020
Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohortWilliam Z Zhang, Michelle C Rice, Katherine L Hoffman, et al.
American Journal of Respiratory and Critical Care Medicine|May 10, 2022
Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary DiseaseSiddharth S Madapoosi, Charmion Cruickshank-Quinn, Kristopher Opron, et al.
The Lancet. Digital Health|January 27, 2023
Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation studyMuhammad F A Chaudhary, Eric A Hoffman, Junfeng Guo, et al.
American Journal of Respiratory and Critical Care Medicine|March 20, 2024
The Effect of Chronic Altitude Exposure on Chronic Obstructive Pulmonary Disease Outcomes in the SPIROMICS Cohort: An Observational Cohort StudyRajat Suri, Daniela Markovic, Han Woo, et al.
Annals of the American Thoracic Society|March 11, 2025
Longitudinal Outcomes in Pi*MZ Alpha-1 Antitrypsin Deficient Individuals with Tobacco Smoking History from the SPIROMICS CohortIgor Barjaktarevic, Roxana Hixson, Zian Zhuang, et al.
Annals of the American Thoracic Society|November 25, 2024
Phenotypes and Trajectories of Tobacco-exposed Persons with Preserved Spirometry: Insights from Lung VolumesMehrdad Arjomandi, Siyang Zeng, Igor Barjaktarevic, et al.
American Journal of Respiratory and Critical Care Medicine|October 2, 2020
Contribution of Individual and Neighborhood Factors to Racial Disparities in Respiratory OutcomesChinedu O Ejike, Han Woo, Panagis Galiatsatos, et al.
Annals of the American Thoracic Society|May 2, 2017
Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study CohortCarlos H Martinez, Susan Murray, R Graham Barr, et al.
Journal of Medicinal Chemistry|June 2, 2012
Diphenylpyridylethanamine (DPPE) derivatives as cholesteryl ester transfer protein (CETP) inhibitorsLalgudi S Harikrishnan, Heather J Finlay, Jennifer X Qiao, et al.
JCI Insight|June 24, 2024
Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohortWilliam Z Zhang, Michelle C Rice, Katherine L Hoffman, et al.
Pageof 26